康哲药业（867.HK;8A8.SG）长效抗IL-4Rα人源化单抗注射液MG-K10特应性皮炎适应症中国NDA已获受理
Oct 30, 2025 18:27 HKT |  |
|
康哲藥業（867.HK;8A8.SG）長效抗IL-4Rα人源化單抗注射液MG-K10特應性皮炎適應症中國NDA已獲受理
Oct 30, 2025 18:27 HKT | |
|
康哲藥業（867.HK; 8A8.SG）簽訂眼科藥物諾適得(R)與倍優適(R)經銷協議
Oct 28, 2025 18:22 HKT | |
|
CMS (867.HK; 8A8.SG) Signed A Distribution Agreement for Ophthalmic Drugs Lucentis(R) and Beovu(R)
Oct 27, 2025 22:00 HKT | |
|
康哲药业（867.HK; 8A8.SG）签订眼科药物诺适得(R)与倍优适(R)经销协议
Oct 27, 2025 18:29 HKT | |
|
康基医疗与Knight Bidco联合发布私有化建议计划文件
Oct 13, 2025 10:14 HKT | |
|
康基醫療與Knight Bidco聯合發佈私有化建議計劃文件
Oct 13, 2025 10:14 HKT | |
|
Kangji Medical and Knight Bidco Jointly Dispatch Scheme Document for Privatisation Proposal
Oct 13, 2025 10:14 HKT | |
|
長風藥業於香港聯合交易所主板成功上市
Oct 08, 2025 17:38 HKT |  |
|
China Medical System (867.HK; 8A8.SG) Positive Results from China Phase 3 Clinical Trial of Innovative Drug Ruxolitinib Cream with AD Indication
Sep 28, 2025 15:00 HKT | |
|
康哲药业（867.HK；8A8.SG）创新药磷酸芦可替尼乳膏AD中国三期临床取得积极结果
Sep 28, 2025 11:33 HKT | |
|
康哲藥業（867.HK；8A8.SG）創新藥磷酸蘆可替尼乳膏AD中國三期臨床取得積極結果
Sep 28, 2025 11:33 HKT | |
|
WORK Medical enters strategic partnerships in bid to explore RWA initiatives
Sep 24, 2025 22:30 HKT | |
|
China Medical System (867.HK; 8A8.SG) Signed Collaboration Agreements for Two Innovative Biologics Used for Passive Immunization Against Tetanus and Rabies
Sep 23, 2025 12:15 HKT | |
|
康哲药业就用于破伤风被动免疫和狂犬病被动免疫的两款创新生物制剂达成合作
Sep 23, 2025 11:16 HKT | |
|
康哲藥業就用於破傷風被動免疫和狂犬病被動免疫的兩款創新生物製劑達成合作
Sep 23, 2025 11:16 HKT | |
|
中國銀河證券重申現代牙科(03600.HK)「增持」評級 目標價調升至6.88港元
Sep 18, 2025 16:30 HKT |  |
|
CGSI Reiterates 'Add' Rating on Modern Dental (03600.HK) with Raised Target Price of HK$6.88
Sep 18, 2025 16:30 HKT | |
|
HKTDC releases research report on biomedicine, Industry development drives GBA global tech leadership
Sep 15, 2025 15:19 HKT |  |
|
现代牙科集团2025年中期净利润升34.7%
Aug 29, 2025 09:25 HKT | |
|